Replacing one serving of sugary drink every day may lower diabetes risk
the ONA take:
According to research published in the journal Diabetologia, researchers have found that replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes by 14 to 25%.
Specifically, researchers found that replacing a serving of a soft drink with water, unsweetened tea, or coffee cuts the risk of diabetes by 14%. Replacing a serving of a sweetened milk beverage with either of the three reduces the risk by 20-25%.
The study also showed that for each 5% of higher intake of energy from total sweet beverages was linked with an 18% increased risk for diabetes.
The researchers determined that if participants had decreased the energy they obtained from sweet beverages to below 2% of total daily energy, 15% of new diabetes cases could be avoided.
"Our new findings on the potential to reduce the burden of diabetes by reducing the percentage of energy consumed from sweet beverages add further important evidence to the recommendation from the World Health Organization to limit the intake of free sugars in our diet," lead researcher Dr. Nita Forouhi, of the UK Medical Research Council Epidemiology Unit, University of Cambridge, said.
Replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|